Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome.

Comparison of Mortality and Complication Rates (Re-myocardial Infarction, Heart Failure, Re-hospitalization, Stroke) After 12 Months Between Two Groups of Patients Undergoing Early Invasive and Late Invasive Strategies in Patients With Elderly Patients With High - Risk Non-ST-segment Elevation Acute Coronary Syndrome.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06486233

Enrollment

385

Registered

2024-07-03

Start date

2024-02-22

Completion date

2028-03-01

Last updated

2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

percutaneous coronary intervention, elderly, non-ST-segment Elevation

Brief summary

The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions. Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Inclusion criteria

* aged 60 years and older * high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards). * receives reperfusion intervention.

Exclusion criteria

* Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion. * Incomplete medical records.

Design outcomes

Primary

Measure	Time frame	Description
In-hospital death	one month	recorded when death occurs during treatment or is confirmed by in-hospital monitoring

Secondary

Measure	Time frame	Description
after 12 months death	one year	determined by the patient follow-up period from hospital discharge until results were recorded
MACE after 12 months include re-admission, recurrent myocardial infarction , stroke, heart failure	one year	recorded

Countries

Vietnam

Contacts

Primary ContactSang Thanh Nguyen, Doctor

drsangthanhnguyen@gmail.com+84902489252

Outcome results